Avanos Medical (Germany) Performance
| 8HH Stock | EUR 17.60 0.20 1.15% |
The firm shows a Beta (market volatility) of 1.56, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Avanos Medical will likely underperform. At this point, Avanos Medical has a negative expected return of -0.23%. Please make sure to confirm Avanos Medical's standard deviation, jensen alpha, and the relationship between the coefficient of variation and information ratio , to decide if Avanos Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Avanos Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 111.5 M | |
| Total Cashflows From Investing Activities | -21 M |
Avanos |
Avanos Medical Relative Risk vs. Return Landscape
If you would invest 2,120 in Avanos Medical on September 12, 2024 and sell it today you would lose (360.00) from holding Avanos Medical or give up 16.98% of portfolio value over 90 days. Avanos Medical is currently producing negative expected returns and takes up 3.1162% volatility of returns over 90 trading days. Put another way, 27% of traded stocks are less volatile than Avanos, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Avanos Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avanos Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Avanos Medical, and traders can use it to determine the average amount a Avanos Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0752
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 8HH |
Estimated Market Risk
| 3.12 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Avanos Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avanos Medical by adding Avanos Medical to a well-diversified portfolio.
Avanos Medical Fundamentals Growth
Avanos Stock prices reflect investors' perceptions of the future prospects and financial health of Avanos Medical, and Avanos Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avanos Stock performance.
| Return On Equity | 0.0348 | |||
| Return On Asset | 0.0236 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 46.5 M | |||
| Price To Earning | 108.36 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 744.6 M | |||
| EBITDA | 47.4 M | |||
| Cash And Equivalents | 288.1 M | |||
| Cash Per Share | 6.05 X | |||
| Total Debt | 130 M | |||
| Debt To Equity | 25.60 % | |||
| Book Value Per Share | 27.11 X | |||
| Cash Flow From Operations | 87.3 M | |||
| Earnings Per Share | 0.87 X | |||
| Total Asset | 1.59 B | |||
About Avanos Medical Performance
By analyzing Avanos Medical's fundamental ratios, stakeholders can gain valuable insights into Avanos Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Avanos Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Avanos Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients quality of life worldwide. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. AVANOS MEDICAL operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4700 people.Things to note about Avanos Medical performance evaluation
Checking the ongoing alerts about Avanos Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Avanos Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avanos Medical generated a negative expected return over the last 90 days | |
| Avanos Medical has high historical volatility and very poor performance | |
| Over 95.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Avanos Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avanos Medical's stock is overvalued or undervalued compared to its peers.
- Examining Avanos Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avanos Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avanos Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avanos Medical's stock. These opinions can provide insight into Avanos Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Avanos Stock analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |